SERPINB5 and carcinoma: As previously reported, maspin immunoreactivity was obtained in 87% of carcinoma tissues and in most of normal epithelium with intestinal metaplasia; however, none of the normal epithelium samples without intestinal metaplasia showed positive immunoreactivity to maspin protein.